Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ideaya Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IDYA
Nasdaq
8731
https://www.ideayabio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ideaya Biosciences Inc
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Apr 26th, 2024 10:00 am
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
- Apr 24th, 2024 2:05 pm
IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer
- Apr 22nd, 2024 10:00 am
IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event
- Apr 1st, 2024 10:00 am
TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal
- Mar 27th, 2024 1:25 pm
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
- Mar 12th, 2024 10:00 am
IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events
- Mar 4th, 2024 11:00 am
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results
- Feb 23rd, 2024 10:54 am
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
- Feb 20th, 2024 11:00 am
IDEAYA Biosciences Inc CEO Yujiro Hata Sells 99,372 Shares
- Feb 13th, 2024 10:37 am
IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events
- Feb 1st, 2024 11:00 am
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is largely controlled by institutional shareholders who own 77% of the company
- Jan 29th, 2024 12:10 pm
IDEAYA Biosciences Inc President and CEO Yujiro Hata Sells 75,000 Shares
- Jan 18th, 2024 6:03 am
IDEAYA Biosciences, Inc. (IDYA) Moves 7.6% Higher: Will This Strength Last?
- Jan 15th, 2024 12:03 pm
IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance
- Jan 7th, 2024 2:00 pm
IDEAYA Biosciences to Participate in Upcoming December 2023 Investor Relations Event
- Dec 5th, 2023 11:00 am
IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
- Dec 4th, 2023 11:00 am
IDEAYA Announces Agenda for Investor R&D Day Webcast on December 4, 2023
- Dec 3rd, 2023 2:00 pm
Can IDEAYA Biosciences, Inc. (IDYA) Climb 25.48% to Reach the Level Wall Street Analysts Expect?
- Nov 14th, 2023 2:55 pm
Analysts' Revenue Estimates For IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Are Surging Higher
- Nov 9th, 2023 10:06 am
Scroll